For patients with COVID-19-associated acute kidney injury (AKI), the postdischarge rate of decrease in kidney function is greater than in AKI patients without COVID-19, reports a paper in JAMA Network Open.
The retrospective study included two groups of patients with AKI treated at five hospitals in a New England health system from March through August 2020. One hundred eighty-two patients had COVID-19-associated AKI, with positive results on a SARS-CoV-2 reverse transcription-polymerase chain reaction test at a study hospital. Another 1430 patients had AKI not associated with COVID-19. In both groups, all patients survived past discharge, did not require